Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2019-06-21 2019-06-21
Drug Identification Number 02409356 02409356
Brand name TIGECYCLINE TIGECYCLINE
Common or Proper name TIGECYCLINE TIGECYCLINE
Company Name APOTEX INC APOTEX INC
Ingredients TIGECYCLINE TIGECYCLINE
Strength(s) 50MG 50MG
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 5ML VIAL 5ML VIAL
ATC code J01AA J01AA
ATC description TETRACYCLINES TETRACYCLINES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2020-01-01 2020-01-01
Actual discontinuation date
Remaining supply date 2020-01-01 2020-01-01
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Information on remaining supply
Company comments
Health Canada comments